Search Results

There are 6974 results for: content related to: Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin

  1. Effect of silibinin in human colorectal cancer cells: Targeting the activation of NF-κB signaling

    Molecular Carcinogenesis

    Volume 52, Issue 3, March 2013, Pages: 195–206, Komal Raina, Chapla Agarwal and Rajesh Agarwal

    Article first published online : 15 NOV 2011, DOI: 10.1002/mc.21843

  2. Injectable and biodegradable poly(organophosphazene) gel containing silibinin: Its physicochemical properties and anticancer activity

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 7, July 2012, Pages: 2382–2391, Jung-Kyo Cho, Jung Won Park and Soo-Chang Song

    Article first published online : 4 APR 2012, DOI: 10.1002/jps.23137

  3. Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking

    Cellular Microbiology

    Volume 15, Issue 11, November 2013, Pages: 1866–1882, Julie Blaising, Pierre L. Lévy, Claire Gondeau, Capucine Phelip, Mihayl Varbanov, Elodie Teissier, Florence Ruggiero, Stephen J. Polyak, Nicholas H. Oberlies, Tijana Ivanovic, Steeve Boulant and Eve-Isabelle Pécheur

    Article first published online : 13 JUN 2013, DOI: 10.1111/cmi.12155

  4. You have free access to this content
    Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease

    Journal of Veterinary Internal Medicine

    Volume 27, Issue 1, January/February 2013, Pages: 10–16, E.S. Hackett, D.C. Twedt and D.L. Gustafson

    Article first published online : 9 NOV 2012, DOI: 10.1111/jvim.12002

  5. Silibinin protects OTA-mediated TNF-α release from perfused rat livers and isolated rat Kupffer cells

    Molecular Nutrition & Food Research

    Volume 53, Issue 4, April 2009, Pages: 460–466, Lauy Al-Anati, Ebtisam Essid, Roland Reinehr and Ernst Petzinger

    Article first published online : 20 JAN 2009, DOI: 10.1002/mnfr.200800110

  6. You have free access to this content
    Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 1262–1271, Stephen J. Polyak, Peter Ferenci and Jean-Michel Pawlotsky

    Article first published online : 28 FEB 2013, DOI: 10.1002/hep.26179

  7. Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways

    Journal of Cellular Biochemistry

    Volume 113, Issue 5, May 2012, Pages: 1733–1743, Jir-You Wang, Chia-Chi Chang, Chao-Ching Chiang, Wei-Ming Chen and Shih-Chieh Hung

    Article first published online : 15 MAR 2012, DOI: 10.1002/jcb.24043

  8. Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells

    Journal of Cellular Physiology

    Volume 210, Issue 2, February 2007, Pages: 385–397, Jun Sik Lee, Sang Gap Kim, Hyung Keun Kim, Tae-Hyung Lee, Young-Il Jeong, Chang-Min Lee, Man-Soo Yoon, Yong Jin Na, Dong-Soo Suh, Nam Cheol Park, In-hak Choi, Gi-Young Kim, Yung Hyun Choi, Hae Young Chung and Yeong-Min Park

    Article first published online : 20 OCT 2006, DOI: 10.1002/jcp.20852

  9. Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels

    BJU International

    Volume 100, Issue 2, August 2007, Pages: 438–444, Catherine W. Cheung, Paul J. Taylor, Carl M.J. Kirkpatrick, David A. Vesey, Glenda C. Gobe, Clay Winterford, David L. Nicol and David W. Johnson

    Article first published online : 4 JUL 2007, DOI: 10.1111/j.1464-410X.2007.07012.x

  10. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling

    Journal of Cellular Biochemistry

    Volume 110, Issue 5, 1 August 2010, Pages: 1111–1122, Wen Ai, Yan Zhang, Qi-Zhu Tang, Ling Yan, Zhou-Yan Bian, Chen Liu, He Huang, Xue Bai, Lu Yin and Hongliang Li

    Article first published online : 1 JUN 2010, DOI: 10.1002/jcb.22623

  11. High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy

    Journal of Viral Hepatitis

    Volume 19, Issue 8, August 2012, Pages: 547–553, M. Biermer, B. Schlosser, B. Fülöp, F. van Bömmel, A. Brodzinski, R. Heyne, K. Keller, C. Sarrazin and T. Berg

    Article first published online : 29 DEC 2011, DOI: 10.1111/j.1365-2893.2011.01572.x

  12. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts

    Journal of Cellular Biochemistry

    Volume 113, Issue 1, January 2012, Pages: 247–259, Jung-Lye Kim, Sang-Wook Kang, Min-Kyung Kang, Ju-Hyun Gong, Eun-Sook Lee, Seoung Jun Han and Young-Hee Kang

    Article first published online : 9 DEC 2011, DOI: 10.1002/jcb.23351

  13. Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells

    Molecular Carcinogenesis

    Volume 30, Issue 4, 2001, Pages: 224–236, Yogesh Sharma, Chapla Agarwal, Ashvani K. Singh and Rajesh Agarwal

    Article first published online : 30 APR 2001, DOI: 10.1002/mc.1032

  14. You have free access to this content
    Silibinin Is a Potent Sensitizer of UVA Radiation-induced Oxidative Stress and Apoptosis in Human Keratinocyte HaCaT Cells

    Photochemistry and Photobiology

    Volume 88, Issue 5, September/October 2012, Pages: 1135–1140, Sreekanth Narayanapillai, Chapla Agarwal, Cynthia Tilley and Rajesh Agarwal

    Article first published online : 10 JAN 2012, DOI: 10.1111/j.1751-1097.2011.01050.x

  15. You have free access to this content
    Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model

    Acta Ophthalmologica

    Volume 91, Issue 7, November 2013, Pages: e506–e515, Yi-Hao Chen, Chang-Min Liang, Ching-Long Chen, Jiann-Torng Chen, Yun-Hsiang Chang, Da-Wen Lu, Ke-Hung Chien and Ming-Cheng Tai

    Article first published online : 13 JUN 2013, DOI: 10.1111/aos.12160

  16. Prostate cancer chemoprevention by silibinin: Bench to bedside

    Molecular Carcinogenesis

    Volume 45, Issue 6, June 2006, Pages: 436–442, Rana P. Singh and Rajesh Agarwal

    Article first published online : 24 APR 2006, DOI: 10.1002/mc.20223

  17. Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells

    Molecular Carcinogenesis

    Volume 53, Issue 3, March 2014, Pages: 169–180, Chandagirikoppal V. Kavitha, Gagan Deep, Subhash C. Gangar, Anil K. Jain, Chapla Agarwal and Rajesh Agarwal

    Article first published online : 31 OCT 2012, DOI: 10.1002/mc.21959

  18. You have free access to this content
    Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells

    International Journal of Cancer

    Volume 120, Issue 9, 1 May 2007, Pages: 2028–2033, Thomas W. Flaig, Lih-Jen Su, Gail Harrison, Rajesh Agarwal and Leonard Michael Glodé

    Article first published online : 17 JAN 2007, DOI: 10.1002/ijc.22465

  19. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation

    Molecular Carcinogenesis

    Cynthia Tilley, Gagan Deep, Chapla Agarwal, Michael F. Wempe, David Biedermann, Kateřina Valentová, Vladimir Kren and Rajesh Agarwal

    Article first published online : 9 DEC 2014, DOI: 10.1002/mc.22253

  20. Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3

    BJU International

    Volume 99, Issue 2, February 2007, Pages: 454–460, Catherine W. Cheung, David A. Vesey, David L. Nicol and David W. Johnson

    Article first published online : 19 JAN 2007, DOI: 10.1111/j.1464-410X.2007.06571.x